Progenity Acquires Carmenta Bioscience for Undisclosed Sum

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e2f203c-62ab-43b4-852c-1c3dd2741981
Date
4/30/2015
Company Name
Carmenta Bioscience
Mailing Address
4240 Wilkie Way Palo Alto, CA 94306 USA
Company Description
Carmenta Bioscience, Inc., is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.
Website
http://www.carmentabio.com
Transaction Type
M&A
Transaction Amount
Undisclosed
Transaction Round
Proceeds Purposes
M&A Terms
Financial terms of the transaction were not disclosed by the companies.